No hay evidencias de que las gafas con ‘filtro de luz azul’ en realidad ayuden a los ojos
VIERNES, 18 de agosto de 2023 (HealthDay News) — Las personas que usan pantallas de forma intensa con frecuencia compran gafas que filtran la luz azul para proteger sus ojos, pero tal vez esté tirando el dinero, sugiere un nuevo estudio. Una nueva re…
Learn MoreRates of Primary Care Physician Vision Testing Examined in Children
MONDAY, Aug. 21, 2023 (HealthDay News) — The rate of primary care physician (PCP) vision testing is about 30 percent for children aged 3 to 17 years and is lower for uninsured and publicly insured children, according to a research letter published on…
Learn MoreBlinded by Chemical Burns, Patients Regained Sight With New Stem Cell Therapy
FRIDAY, Aug. 18, 2023 (HealthDay News) — Phillip Durst was working near an industrial dishwasher when something went awry, and the machinery spewed caustic chemicals into his eyes.“If I had been standing a foot left or right, it wouldn’t have hit me …
Learn MoreNo Evidence ‘Blue Light-Filtering’ Glasses Actually Help Eyes
FRIDAY, Aug. 18, 2023 (HealthDay News) — Heavy screen users often buy blue light-filtering eyeglasses to protect their eyes — but they may be wasting their money, a new study suggests.A new research review suggests these blue light-filtering glasses…
Learn MoreFDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
WEDNESDAY, Aug. 9, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related macular degeneration.The approval was ba…
Learn MoreLiving in Warm Average Temperatures Tied to Vision Impairment in Older Adults
FRIDAY, Aug. 4, 2023 (HealthDay News) — Consistently living in areas with higher average temperatures is associated with severe vision impairment in older adulthood, according to a study published online June 20 in Ophthalmic Epidemiology.Esme Fuller…
Learn MoreFDA Approves Xdemvy for Demodex Blepharitis
FRIDAY, July 28, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Xdemvy (lotilaner ophthalmic solution) 0.25 percent for the treatment of Demodex blepharitis, caused by Demodex mites.The approval was based on results from t…
Learn MoreLa detección temprana del glaucoma es esencial
VIERNES, 14 de julio de 2023 (HealthDay News) — El tratamiento puede controlar los síntomas del tipo más común de glaucoma, y salvar la visión de una persona. El problema es que una persona no puede sentir los cambios en la presión ocular que pueden …
Learn MoreAtropine 0.01 Percent Eye Drops Do Not Slow Myopia Progression
MONDAY, July 17, 2023 (HealthDay News) — For children aged 5 to 12 years with low-to-moderate bilateral myopia, atropine 0.01 percent eye drops do not slow myopia progression over two years of treatment, according to a study published online July 13 …
Learn MoreAll Types of Visual Impairment Linked to Dementia Prevalence
FRIDAY, July 14, 2023 (HealthDay News) — All types of visual impairment (VI) and contrast sensitivity (CS) are associated with increased prevalence of dementia in U.S. older adults, according to a study published online July 13 in JAMA Ophthalmology….
Learn More